Clinical Trial Update: Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cetuximab plus capecitabine in metastatic colorectal cancer that progressed after irinotecan treatment was terminated; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Cetuximab (cetuximab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-08-28